icometrix

Data-driven insights and personalized patient care for conditions such as multiple sclerosis, brain trauma, epilepsy, stroke, dementia, and Alzheimer’s disease.

Company Overview

Founded in 2011, icometrix (Leuven, Belgium; Boston, USA) strives for data-driven insights and personalized patient care, supported by artificial intelligence.

Their solution, icobrain extracts data from brain MRI and CT scans for the radiological reporting and clinical management of neurological disorders such as multiple sclerosis, brain trauma, epilepsy, stroke, dementia, and Alzheimer’s disease. 

icometrix is internationally active and connected to more than 500 clinical practices. In addition, icometrix supports pharmaceutical companies in phase I-III and Real-World Evidence (RWE) studies through imaging and data services, and digital health strategy.

The American Medical Association (AMA) has granted a new CPT Category III code for quantitative brain MRI analysis software. This is only the 5th code of this kind, and the first for brain imaging.

icometrix logo

Modalities

MRI-icon-2-150x150
MRI-icon-1-150x150

Subspecialities

Neuro-icon-150x150

Applications available

icometrix logo

icometrix icobrain

Data-driven insights for conditions such as multiple sclerosis, brain trauma, epilepsy, stroke, dementia, and Alzheimer’s disease.​

FDA

CE

UKCA

SwissMedic

MDALL

tga

MR

Neuro

To find out more about icometrix's solutions, or the 100+ other applications on the Blackford Platform, book a discovery call with our team.

review image 1

Book a meeting

We’d welcome the opportunity to learn more about your AI needs and to explain how partnering with Blackford can drive efficiency and provide ongoing value.

Book a Meeting